BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Wang J, Yu S, Yuan G, He S. Letter to the Editor: Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis: Contrast-Enhanced Ultrasound May Be a Choice. Hepatology 2020;71:392. [PMID: 31222762 DOI: 10.1002/hep.30819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yoon JH, Lee JM, Lee DH, Joo I, Jeon JH, Ahn SJ, Kim ST, Cho EJ, Lee JH, Yu SJ, Kim YJ, Yoon JH. A Comparison of Biannual Two-Phase Low-Dose Liver CT and US for HCC Surveillance in a Group at High Risk of HCC Development. Liver Cancer 2020;9:503-17. [PMID: 33083277 DOI: 10.1159/000506834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wu H, Wang MD, Liang L, Xing H, Zhang CW, Shen F, Huang DS, Yang T. Nanotechnology for Hepatocellular Carcinoma: From Surveillance, Diagnosis to Management. Small 2021;17:e2005236. [PMID: 33448111 DOI: 10.1002/smll.202005236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sun LY, Du ZM, Liu YY, Li YH, Liu XM, Wang T, Shao JY. Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors. Cancers (Basel) 2021;13:664. [PMID: 33562269 DOI: 10.3390/cancers13040664] [Reference Citation Analysis]
4 Sun LY, Ouyang Q, Cen WJ, Wang F, Tang WT, Shao JY. A Model Based on Artificial Intelligence Algorithm for Monitoring Recurrence of HCC after Hepatectomy. Am Surg 2021;:31348211063549. [PMID: 34894786 DOI: 10.1177/00031348211063549] [Reference Citation Analysis]